Navigation Links
Lumenis Sues Alma Lasers and its 4 founders for 200 Million Shekels
Date:3/26/2008

Claims that Alma founders, former Lumenis employees, misappropriated core

technology from Lumenis

YOKNEAM, Israel, March 26 /PRNewswire/ -- Lumenis Ltd. today filed a complaint in the Tel Aviv District Court in Israel against Alma Lasers Ltd. and its four founders, Ziv Karni, Yoav Avni, Nadav Bayer, and Ivgeni Kodritzki, all former employees of Lumenis, claiming misappropriation of Lumenis trade secrets and technology and for the use of such technology in Alma's primary Harmony products, which are sold worldwide. Lumenis has requested relief from the court in the form of an injunction against the use of such core technology by Alma in its products and for monetary damages in the amount of 200 million shekels based on the profits earned by Alma and its founders from the utilization of such Lumenis technology. Lumenis will also be filing a similar action against Alma Inc., the US subsidiary and distribution arm of Alma, in the Federal Court in the US.

The complaint alleges that certain core components of Alma's Harmony products are virtually identical to Lumenis components that were developed around the time the Alma founders departed from Lumenis. The complaint further alleges that at the time the four Alma founders left Lumenis to establish Alma, they were each involved in the development of Lumenis technology and products -- Ziv Karni was the head of Lumenis' R&D; Yoav Avni was employed as a mechanical engineer; Nadav Bayer was the manager of the electronics department, and Ivgeni Kodritzki worked as an electric and electronic engineer.

The claim further alleges that Alma has earned significant revenues from the sales of Harmony products -- profits that were unjustly earned as a result of the use of Lumenis technology. In addition, Alma's founders were recently paid substantial amounts by TA Associates as part of an investment agreement in Alma, profits which resulted from value created by Lumenis technology. '/>"/>

SOURCE Lumenis Ltd.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2

Related medicine news :

1. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
2. Lumenis Ltd. Announces Senior Leadership Appointments Strengthening the Companys Strategic Businesses
3. Alma Lasers Answers Lumenis Complaint
4. Lumenis(R) Seeks Shareholder Approval of Proposed Class Action Settlement
5. Alma Lasers Announces Proposed Initial Public Offering
6. Alma(TM) Lasers to Debut Five New Products at the 66th Annual Meeting of the American Academy of Dermatology
7. FalconStor Software Inc. Founders Make Multi-Million Dollar Donation to North Shore-LIJ Health System for Asian Community Health Center in Flushing
8. Healthy Coffee USA Launches Founders Club
9. Wendell Tyler, of San Francisco 49ers Super Bowl XIX Fame, Joins Healthy Coffee USAs Founders Club
10. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
11. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013 ... will be holding a lupus ... on June 10th. , Meeting ... 6:30 p.m. – 8 p.m., ... from Sparrow Hospital),                  1200 ...
(Date:5/20/2013)... 20, 2013 yurbuds®, maker of the ... today announced the launch of its new Signature Series ... Jacobs, with more signature athletes to come. Created with ... Series ITE 100 is the perfect training partner for ... 100 features reflective, tangle-resistant Kevlar cords, premium sound quality ...
(Date:5/20/2013)... at Galveston researchers have been awarded a five-year, $1.8 ... and Stroke to apply the techniques of gene therapy ... pain that arises from a malfunction in the nervous ... for millions of Americans, manifesting itself in a variety ... feel intense discomfort in response to a light touch, ...
(Date:5/20/2013)... 20, 2013 Stemedica Cell ... stem cell manufacturing, research and development, announced today ... and Director of Interventional Cardiology Research at the ... Scientific and Medical Advisory Board for Stemedica’s Cardiology ... Dr. Wilensky divides his time between the cardiac ...
(Date:5/20/2013)... York (PRWEB) May 20, 2013 The nationwide ... study has found that magnetic resonance imaging (MRI) can be ... of whether or not patients are experiencing symptoms. According ... Journal of Bone & Joint Surgery, MRI detected synovitis (tissue ... patients suffering symptoms due to mechanical causes, the detection rate ...
Breaking Medicine News(10 mins):Health News:yurbuds Expands Best-Selling Lines with Innovative New Products 2Health News:Pain, pain, go away 2Health News:Pain, pain, go away 3Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 2Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 3Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 2Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 3Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 4
... by ticks , THURSDAY, Oct. 4 (HealthDay News) -- Many ... may actually have been bitten by another tick and have ... "It is striking how often re-infection appears to occur," lead ... York Medical College, said in a prepared statement. "Our findings ...
... Institute of Child Health and Human Development (NICHD) announced ... was awarded a competitive contract to participate in the ... be conducted in the United States to assess the ... human health. The study will follow 100,000 children from ...
... A 1998 settlement designed to limit the marketing of smokeless ... University of Georgia study published in the early online edition ... rates are significant and have been very stable over the ... the UGA Grady College of Journalism and Mass Communication. We ...
... Oct. 4 Nastech Pharmaceutical,Company Inc. (Nasdaq: ... "Rick",Costantino, Ph.D., to Chief Scientific Officer of Delivery. ... development of new,drug delivery technologies for peptide and ... since 2003, is retiring,tomorrow, October 5, 2007, as ...
... Energizer has forged a,national partnership with Susan ... its,encouraging message-the Power to Keep Going(R)-to more than ... (Photo: http://www.newscom.com/cgi-bin/prnh/20071004/AQTH013 ) Officials with ... a,special one. Energizer is the battery known around ...
... which a cell protein protects cancer cells,from a ... target for,improving treatment outcomes for patients., A team ... Medical Research (CCIA), led,by Associate Professor Maria Kavallaris, ... could play an important role in resistance to ...
Cached Medicine News:Health News:Lyme Disease Relapse Often a New Infection 2Health News:UMASS Medical School awarded National Children's Study contract 2Health News:UMASS Medical School awarded National Children's Study contract 3Health News:UMASS Medical School awarded National Children's Study contract 4Health News:UGA study: Youth exposed to smokeless tobacco ads despite settlement 2Health News:UGA study: Youth exposed to smokeless tobacco ads despite settlement 3Health News:Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery 2Health News:Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery 3Health News:Energizer Joins Roster of Susan G. Komen Race for the Cure(R) National Sponsors; Energizer(R) ReTreat Pampers Cancer Survivors With Traveling Mini-Spa 2Health News:Energizer Joins Roster of Susan G. Komen Race for the Cure(R) National Sponsors; Energizer(R) ReTreat Pampers Cancer Survivors With Traveling Mini-Spa 3Health News:Cell skeleton may hold key to overcoming drug resistance in cancer 2
(Date:5/20/2013)... VIEJO , Kalifornien, 20. Mai 2013 ... bekannt, dass das Unternehmen die CE-Kennzeichnung für ... zur Embolisation von Aneurysmen erhalten hat. Das ... Europa bereits mit der kontrollierten Einführung dieser ... bietet die SL-Produktfamilie auch ein verbessertes Handling, ...
(Date:5/20/2013)... 20, 2013  Atlantic Pharmaceuticals, Inc., a specialty ... a unique technology to deter prescription drug abuse ... Anthony Soscia , has been chosen ... Chronicle ,s Health-Care Heroes Awards. The awards are ... to honor individuals and organizations demonstrating excellence and ...
(Date:5/20/2013)... YORK , LONDON , ... , May 20, 2013 ... of Osteoarthritis and Preference for Minimally Invasive Procedures to ... landscape, and market trends for the six arthroscopy device ... (FMSs), arthroscopy implants, arthroscopy radio frequency systems, and arthroscopy ...
Breaking Medicine Technology:Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4
... Oct. 29 Stryker Corporation (NYSE: SYK ... a division of Porex Corporation. Porex Surgical is a ... (PPE) for use primarily in reconstructive surgery of the ... the PPE market with strong brand recognition and considerable ...
... LEIDEN, Netherlands, Oct. 29 Pursuant to the provisions of ... Takeover Bids (Besluit Openbare Biedingen Wft) requiring a public announcement ... offer to provide a status update, Johnson & Johnson (NYSE: ... CRXL ; Swiss Exchange: CRX) provide the following ...
Cached Medicine Technology:Stryker Announces Acquisition of Privately-Held Porex Surgical 2Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 2Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 3Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 4Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 5
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
... Used for catheter positioning and exchange ... of the wire guide coils allows utilization ... a smooth transition to a very flexible ... guide is the most rigid coiled wire ...
Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: